Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Bacterial | 21 | 2018 | 114 | 4.030 |
Why?
|
| Escherichia coli Infections | 9 | 2022 | 41 | 3.500 |
Why?
|
| Escherichia coli O157 | 6 | 2022 | 16 | 2.760 |
Why?
|
| Plasmids | 8 | 2022 | 246 | 1.480 |
Why?
|
| Yersinia pestis | 8 | 2012 | 35 | 1.460 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2019 | 77 | 1.120 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 3 | 2022 | 5 | 1.090 |
Why?
|
| Disease Outbreaks | 4 | 2015 | 155 | 1.030 |
Why?
|
| Plague | 7 | 2012 | 25 | 1.020 |
Why?
|
| Bacteriophages | 3 | 2022 | 44 | 1.010 |
Why?
|
| Phylogeny | 15 | 2022 | 644 | 0.980 |
Why?
|
| Hemolytic-Uremic Syndrome | 2 | 2022 | 4 | 0.970 |
Why?
|
| Sequence Analysis, DNA | 11 | 2017 | 474 | 0.940 |
Why?
|
| Food Microbiology | 3 | 2019 | 34 | 0.920 |
Why?
|
| Anti-Bacterial Agents | 5 | 2022 | 352 | 0.890 |
Why?
|
| Laboratory Infection | 1 | 2022 | 2 | 0.850 |
Why?
|
| Virulence Factors | 4 | 2018 | 113 | 0.830 |
Why?
|
| Genetic Variation | 6 | 2016 | 387 | 0.800 |
Why?
|
| DNA, Bacterial | 8 | 2018 | 186 | 0.750 |
Why?
|
| Colistin | 2 | 2022 | 3 | 0.740 |
Why?
|
| Cholera | 3 | 2016 | 70 | 0.700 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2022 | 30 | 0.690 |
Why?
|
| Cheese | 1 | 2019 | 3 | 0.690 |
Why?
|
| Shigella sonnei | 1 | 2018 | 5 | 0.660 |
Why?
|
| Vibrio cholerae O1 | 2 | 2016 | 11 | 0.630 |
Why?
|
| Escherichia coli | 3 | 2022 | 453 | 0.620 |
Why?
|
| Reperfusion Injury | 4 | 1997 | 57 | 0.530 |
Why?
|
| Escherichia coli Proteins | 3 | 2022 | 126 | 0.510 |
Why?
|
| Genomics | 3 | 2014 | 223 | 0.500 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2014 | 2 | 0.490 |
Why?
|
| Foodborne Diseases | 1 | 2014 | 22 | 0.490 |
Why?
|
| Endemic Diseases | 2 | 2016 | 20 | 0.480 |
Why?
|
| Molecular Sequence Data | 10 | 2015 | 1568 | 0.470 |
Why?
|
| Lung | 4 | 1997 | 446 | 0.440 |
Why?
|
| Virulence | 6 | 2020 | 223 | 0.430 |
Why?
|
| DNA Transposable Elements | 1 | 2012 | 48 | 0.410 |
Why?
|
| Bacillus megaterium | 1 | 2011 | 3 | 0.400 |
Why?
|
| Cattle Diseases | 1 | 2011 | 22 | 0.390 |
Why?
|
| Animals | 20 | 2022 | 15081 | 0.380 |
Why?
|
| Genetic Markers | 1 | 2011 | 142 | 0.370 |
Why?
|
| Genotype | 4 | 2015 | 730 | 0.370 |
Why?
|
| Shiga Toxin 2 | 2 | 2022 | 3 | 0.350 |
Why?
|
| Bacterial Proteins | 5 | 2017 | 540 | 0.320 |
Why?
|
| Shiga Toxin | 2 | 2022 | 5 | 0.310 |
Why?
|
| Wolinella | 2 | 2004 | 3 | 0.310 |
Why?
|
| Molecular Epidemiology | 4 | 2016 | 50 | 0.310 |
Why?
|
| Scarlet Fever | 1 | 2007 | 1 | 0.300 |
Why?
|
| Yersinia pseudotuberculosis Infections | 1 | 2007 | 3 | 0.300 |
Why?
|
| Humans | 24 | 2022 | 37093 | 0.300 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2007 | 7 | 0.300 |
Why?
|
| Cattle | 3 | 2022 | 477 | 0.300 |
Why?
|
| Genome, Fungal | 1 | 2007 | 22 | 0.300 |
Why?
|
| Helicobacter pylori | 2 | 2006 | 109 | 0.300 |
Why?
|
| Helicobacter | 1 | 2006 | 1 | 0.280 |
Why?
|
| Tigers | 1 | 2006 | 1 | 0.280 |
Why?
|
| Lions | 1 | 2006 | 2 | 0.280 |
Why?
|
| Acinonyx | 1 | 2006 | 2 | 0.280 |
Why?
|
| Water Microbiology | 2 | 2016 | 76 | 0.260 |
Why?
|
| Species Specificity | 4 | 2012 | 245 | 0.260 |
Why?
|
| Helicobacter hepaticus | 1 | 2004 | 1 | 0.250 |
Why?
|
| Campylobacter jejuni | 1 | 2004 | 22 | 0.250 |
Why?
|
| Evolution, Molecular | 3 | 2014 | 268 | 0.210 |
Why?
|
| Sequence Analysis | 1 | 2022 | 26 | 0.210 |
Why?
|
| Clone Cells | 1 | 2022 | 47 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2015 | 767 | 0.210 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2012 | 149 | 0.200 |
Why?
|
| Genomic Islands | 2 | 2011 | 14 | 0.180 |
Why?
|
| Genes, Bacterial | 3 | 2012 | 90 | 0.180 |
Why?
|
| Bacterial Adhesion | 2 | 2018 | 37 | 0.170 |
Why?
|
| Military Personnel | 1 | 2020 | 90 | 0.170 |
Why?
|
| Polymorphism, Genetic | 2 | 2011 | 191 | 0.170 |
Why?
|
| Dysentery, Bacillary | 1 | 2018 | 13 | 0.160 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2018 | 16 | 0.160 |
Why?
|
| Immunologic Factors | 1 | 2018 | 45 | 0.160 |
Why?
|
| Thioredoxins | 1 | 2018 | 42 | 0.160 |
Why?
|
| Acinetobacter baumannii | 1 | 2018 | 33 | 0.160 |
Why?
|
| Taurocholic Acid | 1 | 2017 | 7 | 0.150 |
Why?
|
| Amidohydrolases | 1 | 2017 | 11 | 0.150 |
Why?
|
| Neutrophils | 2 | 1995 | 131 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 61 | 0.150 |
Why?
|
| Haiti | 2 | 2014 | 68 | 0.150 |
Why?
|
| Databases, Genetic | 2 | 2014 | 93 | 0.150 |
Why?
|
| Meat | 2 | 2015 | 43 | 0.150 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2016 | 3 | 0.140 |
Why?
|
| Floods | 1 | 2016 | 6 | 0.140 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2016 | 5 | 0.140 |
Why?
|
| Rats | 5 | 2012 | 3483 | 0.140 |
Why?
|
| Ischemia | 1 | 1996 | 46 | 0.140 |
Why?
|
| Interleukin-10 | 1 | 1996 | 75 | 0.140 |
Why?
|
| Nasturtium | 1 | 2015 | 1 | 0.130 |
Why?
|
| Mice | 4 | 2020 | 5913 | 0.130 |
Why?
|
| Nepal | 1 | 2014 | 15 | 0.130 |
Why?
|
| Chromosomes, Bacterial | 2 | 2012 | 20 | 0.130 |
Why?
|
| Microbiology | 1 | 2014 | 2 | 0.120 |
Why?
|
| Genetics, Microbial | 1 | 2014 | 5 | 0.120 |
Why?
|
| Food-Processing Industry | 1 | 2014 | 2 | 0.120 |
Why?
|
| Anthrax | 1 | 2014 | 19 | 0.120 |
Why?
|
| Bacillus anthracis | 1 | 2014 | 33 | 0.120 |
Why?
|
| Base Sequence | 3 | 2012 | 997 | 0.110 |
Why?
|
| Flagella | 2 | 2011 | 29 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 1995 | 316 | 0.110 |
Why?
|
| Food Supply | 1 | 2014 | 112 | 0.110 |
Why?
|
| Rats, Inbred Strains | 3 | 1997 | 133 | 0.110 |
Why?
|
| Bacillus | 1 | 2012 | 8 | 0.110 |
Why?
|
| Conjugation, Genetic | 1 | 2012 | 14 | 0.100 |
Why?
|
| Mutagenesis, Insertional | 1 | 2012 | 32 | 0.100 |
Why?
|
| Prophages | 1 | 2011 | 4 | 0.100 |
Why?
|
| Capillary Permeability | 3 | 1996 | 30 | 0.100 |
Why?
|
| Arsenites | 1 | 2012 | 51 | 0.100 |
Why?
|
| Vibrio cholerae | 1 | 2012 | 98 | 0.100 |
Why?
|
| Incidence | 1 | 2014 | 922 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2011 | 90 | 0.100 |
Why?
|
| Hospitalization | 1 | 2014 | 388 | 0.100 |
Why?
|
| Arsenic | 1 | 2012 | 144 | 0.090 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2009 | 8 | 0.090 |
Why?
|
| Guinea Pigs | 1 | 2010 | 145 | 0.090 |
Why?
|
| Disease Reservoirs | 1 | 2009 | 20 | 0.090 |
Why?
|
| Rodentia | 1 | 2009 | 43 | 0.090 |
Why?
|
| Phenotype | 1 | 2012 | 689 | 0.090 |
Why?
|
| Antigens, Bacterial | 1 | 2010 | 132 | 0.080 |
Why?
|
| China | 1 | 2009 | 196 | 0.080 |
Why?
|
| Chlamydia | 1 | 2009 | 42 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 661 | 0.080 |
Why?
|
| Superantigens | 1 | 2007 | 2 | 0.080 |
Why?
|
| Mycotoxins | 1 | 2007 | 12 | 0.080 |
Why?
|
| Genes, Fungal | 1 | 2007 | 38 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 2009 | 196 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2006 | 381 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2007 | 75 | 0.070 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2006 | 10 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2007 | 151 | 0.070 |
Why?
|
| Carbohydrates | 1 | 2006 | 29 | 0.070 |
Why?
|
| United States | 2 | 2014 | 4223 | 0.070 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2006 | 52 | 0.070 |
Why?
|
| Superoxide Dismutase | 2 | 1997 | 155 | 0.070 |
Why?
|
| Helicobacter Infections | 1 | 2006 | 78 | 0.070 |
Why?
|
| Computational Biology | 2 | 2004 | 293 | 0.060 |
Why?
|
| Genome | 2 | 2015 | 125 | 0.060 |
Why?
|
| Bdellovibrio | 1 | 2004 | 10 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 1609 | 0.050 |
Why?
|
| Public Health | 1 | 2007 | 372 | 0.050 |
Why?
|
| Aneurysm | 1 | 2001 | 6 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 448 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 2001 | 18 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2001 | 19 | 0.050 |
Why?
|
| Endocarditis | 1 | 2001 | 10 | 0.050 |
Why?
|
| Aortic Valve | 1 | 2001 | 23 | 0.050 |
Why?
|
| Kenya | 1 | 2020 | 50 | 0.050 |
Why?
|
| Travel | 1 | 2020 | 32 | 0.050 |
Why?
|
| Diarrhea | 1 | 2020 | 89 | 0.040 |
Why?
|
| Male | 5 | 2001 | 20025 | 0.040 |
Why?
|
| Cecum | 1 | 2017 | 16 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2018 | 166 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2018 | 325 | 0.040 |
Why?
|
| Sepsis | 1 | 2018 | 80 | 0.040 |
Why?
|
| Complement Activation | 1 | 1997 | 13 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 1997 | 21 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1997 | 150 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2017 | 212 | 0.040 |
Why?
|
| Peroxidase | 1 | 1997 | 49 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 431 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 325 | 0.040 |
Why?
|
| Pakistan | 1 | 2016 | 20 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 1996 | 34 | 0.040 |
Why?
|
| Cholera Toxin | 1 | 2016 | 39 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 1995 | 4 | 0.030 |
Why?
|
| Premedication | 1 | 1995 | 4 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2015 | 14 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 201 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 1995 | 80 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 1996 | 237 | 0.030 |
Why?
|
| Animals, Domestic | 1 | 2015 | 8 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1995 | 112 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 240 | 0.030 |
Why?
|
| RNA | 1 | 1997 | 241 | 0.030 |
Why?
|
| Disease Vectors | 1 | 2014 | 10 | 0.030 |
Why?
|
| Reference Standards | 1 | 2014 | 52 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1996 | 356 | 0.030 |
Why?
|
| Georgia | 1 | 2014 | 174 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 808 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2014 | 45 | 0.030 |
Why?
|
| Open Reading Frames | 2 | 2004 | 77 | 0.030 |
Why?
|
| Cytokines | 1 | 1997 | 602 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1371 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2012 | 9 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 89 | 0.030 |
Why?
|
| Madagascar | 1 | 2011 | 7 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 2011 | 18 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2011 | 195 | 0.020 |
Why?
|
| Time Factors | 1 | 1995 | 1742 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 550 | 0.020 |
Why?
|
| Phascolarctidae | 1 | 2009 | 1 | 0.020 |
Why?
|
| Chromosome Inversion | 1 | 2007 | 8 | 0.020 |
Why?
|
| North America | 1 | 2007 | 67 | 0.020 |
Why?
|
| Base Pairing | 1 | 2007 | 42 | 0.020 |
Why?
|
| Peptidoglycan | 1 | 2004 | 7 | 0.010 |
Why?
|
| Hydrolases | 1 | 2004 | 15 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2004 | 24 | 0.010 |
Why?
|
| Fimbriae, Bacterial | 1 | 2004 | 23 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2004 | 22 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 93 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 185 | 0.010 |
Why?
|
| Glycosylation | 1 | 2003 | 100 | 0.010 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 95 | 0.010 |
Why?
|
| Amino Acids | 1 | 2004 | 145 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 196 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2001 | 10 | 0.010 |
Why?
|
| Reoperation | 1 | 2001 | 24 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2001 | 210 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 974 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2001 | 2026 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 1908 | 0.010 |
Why?
|
| Aged | 1 | 2001 | 6741 | 0.010 |
Why?
|
| Middle Aged | 1 | 2001 | 10129 | 0.000 |
Why?
|
| Adult | 1 | 2001 | 11712 | 0.000 |
Why?
|
| Female | 1 | 2001 | 20969 | 0.000 |
Why?
|